Tools for Smoking Cessation
By Erik J. MacLaren, PhD
Posted: October 2017
Scott Gottlieb, MD, Commissioner of the U.S. Food and Drug Administration, said in a recent speech, “There’s probably...
NCI Corner – Interview with Jeff Abrams
NCI Helping to Save Lives and Improve Cancer Survival Rates
Scientific data from clinical trials are essential for evaluating new cancer treatments and setting new...
NCI Corner – Interview with Matthew Holderfield, PhD
Posted: June 2017
NCI to Team Up with Cancer Research UK and the Cancer Research Technology Pioneer Fund on RAS Research
On April 19, 2017, Cancer...
NCI Formulary Holds Promise to Speed Clinical Trials
Posted: April 2017
By Erik T. MacLaren, PhD
On January 11, the National Cancer Institute (NCI) launched a virtual agent formulary (NCI Formulary): a new public-private...
NCI Corner – Interview with Shakun Malik, MD
Posted: February 2017
By Erik J. Maclaren, PhD
2017 Mesothelioma Clinical Trials Planning Meeting
Malignant mesothelioma is one of the most difficult cancers to control using existing...
Lung Cancer and Smoking Cessation: Opportunities for Progress
By Stephanie R. Land, PhD
Tobacco cessation assistance, imperative for tobacco users who seek medical care,1 takes on even greater urgency for individuals who are...
NCI Corner – Interview with Dinah S. Singer, PHD
By Erik J. MacLaren, PhD
Blue Ribbon Panel of the US National Cancer Advisory Board
During his State of the Union address in January 2016, President...
Small Cell Lung Cancer: The Next Challenge
By Peter Ujhazy, MD, PhD
The newfound optimism in the management of lung cancer that infused the research, clinical, and patient communities 12 years ago...
NCI Corner – Interview with Shakun Malik, MD
By Erik J. Mac Laren, PhD
In late 2015, the US National Cancer Institute (NCI) Thoracic Malignancy Steering Committee (TMSC) published its strategic priorities for...
